By Dan Hawtrey
More and more healthcare companies are building their presence on Twitter. Johnson & Johnson, Novartis, Roche, Astra Zeneca, GE Healthcare and Boehringer Ingelheim are all tweeting and being tweeted at. Some companies are even using Twitter to promote specific branded treatments: Novo Nordisk call attention to their Novolog and Levemir diabetes treatments.
In spite of all the hype surrounding Twitter, it looks like these early adopters might be on to something. Whilst still small in comparison to Facebook, Twitter offers something unique: it attracts a lot of content creators and critics – the minority of people who actually create content on the internet as opposed to the majority who merely browse and consume content. These creators are the ones most likely to discuss your brand, either on Twitter itself or on other social networks, such as blogs, message boards, YouTube and so on. For companies, the benefit of Twitter is clear: it’s about seeding your message to the creators so that it finds its way all over the web. It’s all about PR.